Square Pharmaceuticals Limited announced earnings results for the second quarter ended December 31, 2020. For the second quarter, the company announced total revenue was BDT 12,366.059 million compared to BDT 11,129.202 million a year ago. Operating income was BDT 4,194.281 million compared to BDT 3,728.484 million a year ago. Net income was BDT 3,837.629 million compared to BDT 3,531.973 million a year ago. Basic earnings per share from continuing operations was BDT 4.33 compared to BDT 3.98 a year ago. For the half year, total revenue was BDT 24,941.640 million compared to BDT 22,422.785 million a year ago. Operating income was BDT 8,449.959 million compared to BDT 7,419.564 million a year ago. Net income was BDT 7,769.595 million compared to BDT 6,885.810 million a year ago. Basic earnings per share from continuing operations was BDT 8.76 compared to BDT 7.77 a year ago.